Tenet Healthcare (THC) volatility elevated into Q2 and outlook

Go back to Tenet Healthcare (THC) volatility elevated into Q2 and outlook

Mizuho Securities Cuts Price Target on Tenet Healthcare (THC) to $28; Reiterates Neutral

August 2, 2016 8:11 AM EDT

Mizuho Securities maintained a Neutral rating on Tenet Healthcare (NYSE: THC), and cut the price target to $28.00 (from $33.00), following the company's 2Q earnings report.

Analyst Sheryl Skolnick commented, "The Mama issue is not a 'once and done, now it's behind them' thing. It's... More